Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Carmelo Gurnari,1,2 Ishani Nautiyal,1 Simona Pagliuca1,3 1Department of Translational Hematology and Oncology Research, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology,...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2021-12-01
|
| סדרה: | Therapeutics and Clinical Risk Management |
| נושאים: | |
| גישה מקוונת: | https://www.dovepress.com/current-opinions-on-the-clinical-utility-of-ravulizumab-for-the-treatm-peer-reviewed-fulltext-article-TCRM |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|